1Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespanRyan J.Piers1309-13122Roles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous systemYue Wan, Jin-Shan Yang, Li-Cai Xu, Xiao-Jiang Huang, Wei Wang, Min-Jie Xie1313-13213Neuroplasticity, limbic neuroblastosis and neuro-regenerative disordersMahesh Kandasamy, Ludwig Aigner1322-13264A tissue-engineered rostral migratory stream for directed neuronal replacementJohn C.O'Donnell, Kritika S.Katiyar, Kate V.Panzer, D.Kacy Cullen1327-13315Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects:implications for Parkinson's diseaseEoin O'Neill, Andrew Harkin1332-13376Targeting the mitochondrial permeability transition pore in traumatic central nervous system injuryJoe E.Springer, Pareshkumar Prajapati, Patrick G.Sullivan1338-13417Current surgical treatments for Parkinson's disease and potential therapeutic targetsDarrin J.Lee, Robert F.Dallapiazza, Philippe De Vloo, Andres M.Lozano1342-13458Amnion epithelial cells-a novel therapy for ischemic stroke?Megan A.Evans, Brad R.S.Broughton, Grant R.Drummond, Henry Ma, Thanh G.Phan, Euan M.Wallace, Rebecca Lim, Christopher G.Sobey1346-13499Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration:neurophysiological insights into stem progenitor cell neurogenesis within a host environmentOlga Kopach, Tatyana Pivneva1350-135110Stem cell therapy for retinal ganglion cell degenerationLing-Ping Cen, Tsz Kin Ng1352-135311Exercise and hippocampal neurogenesis: a dogma re-examined and lessons learnedPatrick Z.Liu, Robin Nusslock1354-135512Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disordersFabian Maass, Paul Lingor1356-135713Perspectives on "the biology of spinal cord regeneration success and failure"Philippa Mary Warren, Amanda Phuong Tran, Jerry Silver1358-135914Cholinergic receptor, nicotinic, alpha 7 as a target molecule of Arctic mutant amyloid βNaoya Sawamura, Ye Ju, Toru Asahi1360-136115Gamma-aminobutyric acid A receptors in Alzheimer's disease:highly localized remodeling of a complex and diverse signaling pathwayAndrea Kwakowsky, Beatriz Calvo-Flores Guzmán, Karan Govindpani, Henry J.Waldvogel, Richard L.Faull1362-136316Factors contributing to clinical picture and progression of Huntington's diseaseDaniel Zielonka1364-136517Drug repurposing for neuroregeneration in multiple sclerosisPatrick Küry, David Kremer, Peter G(o)ttle1366-136718Advanced glycation end products induce neural tube defects through elevating oxidative stress in miceRu-Lin Li, Wei-Wei Zhao, Bing-Yan Gao1368-137419Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synucleinHuan-Cheng Wu, Qun-Liang Hu, Shi-Jun Zhang, Yan-Min Wang, Zhan-Kui Jin, Ling-Fu Lv, Sai Zhang, Zhen-Lin Liu, Hong-Lian Wu, Ou-Mei Cheng1375-138320Effects of repetitive transcranial magnetic stimulation on cognitive function and cholinergic activity in the rat hippocampus after vascular dementiaXiao-Qiao Zhang, Li Li, Jiang-Tao Huo, Min Cheng, Lin-Hong Li1384-1389 